Eylea Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions
Categories: ,

Description

Exjade (deferasirox) binds to iron and removes it from the bloodstream. Exjade is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old. Exjade is also used to treat chronic iron overload syndrome caused by a genetic blood disorder (non-transfusion-dependent thalassemia) in adults and children who are at least 10 years old.https://www.drugs.com/exjade.html

Related products

Contact US

484-352-2642

Contact Us

Learn More

What is an Adverse Event Report?

The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports, medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.